Nomination Summary for Methdilazine (N80305)
Nominated Substances: Methdilazine
Nomination Date: 11/00/1979
Nominator: FDA
Rationale: potential for wide exposure as possible substitute for the antihistamine methapyrilene which had been shown to induce hepatic tumors in rats